SCHEMBL449524

SCHEMBL449524

CC(=O)CC(=O)OC(=O)CC(C)=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 2/20 0.67
GAA P10253 2/20 0.67
SI P14410 2/20 0.67
MGAM2 Q2M2H8 2/20 0.67
ALDH1A1 P00352 7/20 0.47
TDP1 Q9NUW8 3/20 0.47
TSHR P16473 4/20 0.40
HTT P42858 1/20 0.39
KDM4E B2RXH2 3/20 0.38
KDM6B O15054 1/20 0.38
KDM5C P41229 1/20 0.38
EGLN1 Q9GZT9 1/20 0.38
PHF8 Q9UPP1 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
TRPA1 O75762 1/20 0.37
HSD17B10 Q99714 3/20 0.36
LMNA P02545 3/20 0.33
SLC15A2 Q16348 1/20 0.32
FFAR3 O14843 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19283437 0.91 MGAM (0.57) MGAMGAASIMGAM2ALDH1A1
SCHEMBL8900506 0.91 MGAM (0.57) MGAMGAASIMGAM2ALDH1A1
SCHEMBL9278854 0.89 MGAM (0.55) MGAMGAASIMGAM2ALDH1A1
SCHEMBL27296340 0.89 MGAM (0.55) MGAMGAASIMGAM2ALDH1A1
SCHEMBL28224529 0.88 MGAM (0.60) MGAMGAASIMGAM2ALDH1A1
SCHEMBL9280063 0.88 MGAM (0.60) MGAMGAASIMGAM2ALDH1A1
SCHEMBL8364199 0.88 MGAM (0.60) MGAMGAASIMGAM2ALDH1A1
SCHEMBL586203 0.88 MGAM (0.60) MGAMGAASIMGAM2ALDH1A1
SCHEMBL5615464 0.88 MGAM (0.60) MGAMGAASIMGAM2ALDH1A1
SCHEMBL15847228 0.88 MGAM (0.60) MGAMGAASIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220221792-A1 PATTERN FORMING MATERIAL AND PATTERN FORMING METHOD KIOXIA CORPORATION (JP) 2022-07-14 US claimed
US-11320736-B2 Pattern forming material and pattern forming method KIOXIA CORPORATION (JP) 2022-05-03 US claimed
CN-110627832-A Preparation method for synthesizing tenofovir alafenamide by oxidation method 江西农业大学 2019-12-31 CN claimed
CN-1154700-C Coating compositions containing polyacetoacetate, crosslinker and organosilane 艾狄航空涂料公司 2004-06-23 CN claimed
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same DAIKIN INDUSTRIES, LTD. (JP) 2026-05-05 US disclosed
US-20250260063-A1 ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY DAIKIN INDUSTRIES, LTD. (JP) 2025-08-14 US disclosed
EP-3780232-B1 ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY BATTERY, AND MODULE DAIKIN IND LTD (JP) 2025-07-30 EP disclosed
CN-120077502-A Electrolyte, electrochemical device, secondary battery, and lithium ion secondary battery 大金工业株式会社 2025-05-30 CN disclosed
US-20250174720-A1 ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE DAIKIN INDUSTRIES, LTD. (JP) 2025-05-29 US disclosed
US-12315885-B2 Electrolytic solution, electrochemical device, lithium-ion secondary battery, and module DAIKIN INDUSTRIES, LTD. (JP) 2025-05-27 US disclosed
EP-4553940-A1 SECONDARY BATTERY DAIKIN INDUSTRIES, LTD. (JP) 2025-05-14 EP disclosed
EP-4553918-A1 NEGATIVE ELECTRODE, BATTERY, AND METHOD FOR COVERING BATTERY MATERIAL DAIKIN INDUSTRIES, LTD. (JP) 2025-05-14 EP disclosed
WO-1993023049-A1 3-(9-ACRIDINYLAMINO)-5-HYDROXYMETHYLANILINE DERIVATIVES AS ANTICANCER AGENTS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-11-25 WO disclosed
EP-0217214-A1 2,4-dioxopyrrolo(2,3-c)pyrroles BAYER AG (DE) 1987-04-08 EP disclosed
US-4370499-A CHEMICAL INTERMEDIATES FOR COLOR PHOTOGRAPHY BAYER AKTIENGESELLSCHAFT (DE) 1983-01-25 US disclosed
US-4365086-A CURING AGENTS FOR THERMOPLASTIC ELASTOMERS PENNWALT CORPORATION (US) 1982-12-21 US disclosed
US-4363925-A PALLADIUM COMPLEX AND A PHOSPHINE OR PHOSPHITE CATALYZED REACTION OF A DISILANE AND AN AROMATIC HALIDE BASF AKTIENGESELLSCHAFT (DE) 1982-12-14 US disclosed
US-4328360-A VULCANIZING AGENT FOR THERMOPLASTIC RESINS PENNWALT CORPORATION (US) 1982-05-04 US disclosed
EP-0040408-A1 Beta-lactam compounds and process for production thereof SANRAKU-OCEAN CO., LTD. (JP) 1981-11-25 EP disclosed
US-4052543-A VULCANIZABLE AND VULCANIZED COMPOSITIONS CONTAINING POLYPEROXIDE PENNWALT CORPORATION (US) 1977-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250174720-A1 ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE HCN2, HCN1, HCN3 MGAM 3705/4885GAA 3690/4885SI 4172/4885
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same ASH2L, OLA1, ODC1 MGAM 3291/4885GAA 3344/4885SI 3686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.